Immunotherapy for SARS-CoV-2: potential opportunities

被引：37
|
作者：
Pashaei, Mehrnoosh [1 ]
Rezaei, Nima [1 ,2 ,3 ]
机构：
[1] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[2] Univ Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIIM, Tehran, Iran
[3] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Childrens Med Ctr, Tehran, Iran
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2020年 / 20卷 / 10期
关键词：
Immunotherapy; monoclonal antibodies; severe acute respiratory syndrome coronavirus 2; COVID-19; ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; THERAPY; SPIKE;
D O I：
10.1080/14712598.2020.1807933
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1111 / 1115
页数：5
相关论文
共 50 条
  • [1] Allergen Immunotherapy in the Era of SARS-CoV-2
    Compalati, E.
    Erlewyn-Lajeunesse, M.
    Ali, Runa F.
    Ojeda Fernandez, P.
    Garcia Nunez, I
    Frati, F.
    Mistrello, G.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (06) : 459 - 461
  • [2] CAR Macrophages for SARS-CoV-2 Immunotherapy
    Fu, Wenyan
    Lei, Changhai
    Ma, Zetong
    Qian, Kewen
    Li, Tian
    Zhao, Jian
    Hu, Shi
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] The panzootic potential of SARS-CoV-2
    Mabry, Makenzie E.
    Fanelli, Angela
    Mavian, Carla
    Lorusso, Alessio
    Manes, Costanza
    Soltis, Pamela S.
    Capua, Ilaria
    [J]. BIOSCIENCE, 2023, 73 (11) : 814 - 829
  • [4] ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
    Henden, A.
    Lineburg, K.
    Le Texier, L.
    Raju, J.
    Crooks, P.
    Wright, E.
    Scott, A.
    Neller, M. A.
    Tey, S.
    Khanna, R.
    Smith, C.
    [J]. CYTOTHERAPY, 2023, 25 (06) : S252 - S252
  • [5] Immunotherapy approaches on innate immunity for SARS-Cov-2
    Arslan, B. A.
    Timucin, A. C.
    [J]. ACTA VIROLOGICA, 2020, 64 (04) : 389 - 395
  • [6] Facing SARS-CoV-2 outbreak in immunotherapy era
    Citarella, Fabrizio
    Russano, Marco
    Pantano, Francesco
    Dell'Aquila, Emanuela
    Vincenzi, Bruno
    Tonini, Giuseppe
    Santini, Daniele
    [J]. FUTURE ONCOLOGY, 2020, 16 (20) : 1475 - 1486
  • [7] Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
    Diya Jhuti
    Angeli Rawat
    Christina M. Guo
    Lindsay A. Wilson
    Edward J. Mills
    Jamie I. Forrest
    [J]. Infectious Diseases and Therapy, 2022, 11 : 953 - 972
  • [8] Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
    Jhuti, Diya
    Rawat, Angeli
    Guo, Christina M.
    Wilson, Lindsay A.
    Mills, Edward J.
    Forrest, Jamie, I
    [J]. INFECTIOUS DISEASES AND THERAPY, 2022, 11 (03) : 953 - 972
  • [9] Antimalarial Drugs at the Intersection of SARS-CoV-2 and Rheumatic Diseases: What Are the Potential Opportunities?
    Abisheva, Saule
    Rutskaya-Moroshan, Kristina
    Nuranova, Gulnaz
    Batyrkhan, Tansholpan
    Abisheva, Anilim
    [J]. MEDICINA-LITHUANIA, 2024, 60 (07):
  • [10] Aminoglycosides and their potential as SARS-CoV-2 antivirals
    Cimolai, Nevio
    [J]. MEDICAL HYPOTHESES, 2021, 150
12345